Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial
BioSpace
Fri, 11/30/18 - 10:20 am
Tags:
asthma, Dynavax, AstraZeneca, clinical trials, AZD1419
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Yahoo/Zacks.com
Tue, 11/27/18 - 12:09 pm
Tags:
AstraZeneca, Fasenra, orphan drugs, FDA, eosinophilic granulomatosis with polyangiitis
Is AstraZeneca looking for the ideal candidate to replace Pascal Soriot?
Endpoints
Mon, 11/19/18 - 11:36 am
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
Tags:
cancer, breast cancer, lung cancer, drug approvals, AstraZeneca, Takeda, Ariad Pharmaceuticals, Merck, Pfizer, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Puma Biotechnology, Mylan, Genentech
AstraZeneca may have hit rock bottom, but can it rise to new heights?
Pharmaforum
Sun, 11/18/18 - 12:44 pm
Tags:
AstraZeneca
Grünenthal Snaps up Averitas Pharma for Undisclosed Sum to Extend Presence in the U.S.
BioSpace
Sun, 11/18/18 - 12:43 pm
Tags:
Grunenthal, Germany, M&A, Averitas Pharma, AstraZeneca
AstraZeneca Shows It Can Still Take Some Knocks
Yahoo/Bloomberg
Sat, 11/17/18 - 12:36 pm
Tags:
AstraZeneca, Imfinzi
AstraZeneca’s Mystic OS analysis paints tremelimumab as a dud in NSCLC
Fierce Biotech
Fri, 11/16/18 - 12:19 pm
Tags:
AstraZeneca, clinical trials, tremelimumab, non-small cell lung cancer
A Spark Of Good News For Precision Oncology In Breast Cancer
Forbes
Wed, 11/14/18 - 09:59 am
Tags:
AstraZeneca, triple negative breast cancer, AZD5363, precision medicine
AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis
Endpoints
Tue, 11/13/18 - 10:29 am
Tags:
AstraZeneca, Sobi, Synagis, RSV
AstraZeneca calls victory in CV study, but will payers feel the same?
Biopharma Dive
Mon, 11/12/18 - 11:30 pm
Tags:
AstraZeneca, Farxiga, payers
FDA Accepts sNDA for Lynparza for Maintenance Therapy in Advanced Ovarian Cancer and Grants Priority Review
CP Wire
Mon, 11/12/18 - 10:19 am
Tags:
Lynparza, Merck, AstraZeneca, ovarian cancer, FDA
Mon, 11/12/18 - 09:54 am
Tags:
Lynparza, Merck, AstraZeneca, ovarian cancer
AstraZeneca's diabetes drug curbs heart failure, kidney risks
Yahoo/Reuters
Sun, 11/11/18 - 09:14 pm
Tags:
AstraZeneca, Farxiga, diabetes, heart failure
PARP makers search for a way to break through
Biopharma Dive
Fri, 11/9/18 - 12:08 am
Tags:
AstraZeneca, Clovis Oncology, Tesaro, PARP inhibitors, ovarian cancer
AstraZeneca Reports First Quarter of Sustainable Product Sales Growth Since 2014
BioSpace
Thu, 11/8/18 - 12:24 pm
Tags:
AstraZeneca, earnings
AZ drops midstage cancer drug vistusertib
Fierce Biotech
Thu, 11/8/18 - 12:17 pm
Tags:
AstraZeneca, mTOR inhibitors, vistusertib
AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
BioSpace
Tue, 11/6/18 - 11:46 am
Tags:
AstraZeneca, asthma, rhinitis, Covis Pharma, Alvesco, Omnaris, Zetonna
In another try at lung cancer niche, J&J nabs a potential Tagrisso rival for $50M-plus
Endpoints
Mon, 11/5/18 - 07:17 pm
Tags:
JNJ, Tagrisso, AstraZeneca, Yuhan
AstraZeneca hands over some rights to Nexium, Vimovo to Grünenthal as it plots turnaround
Endpoints
Tue, 10/30/18 - 10:24 am
Tags:
AstraZeneca, Nexium, Vimovo, Grünenthal GmbH

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.